Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis

In a systematic review and meta-analysis published in the journal Molecular Psychiatry, scientists have analyzed recent evidence on the usefulness of single and multimodal neuroimaging techniques in characterizing psychotic disorders.

A meta-analysis and systematic review of single vs. multimodal neuroimaging techniques in the classification of psychosis
Study: A meta-analysis and systematic review of single vs. multimodal neuroimaging techniques in the classification of psychosis. Image Credit: New Africa/Shutterstock.com

Background

Psychosis is a distressing disorder associated with structural and functional abnormalities in different parts of the brain. Structural abnormalities associated with psychosis include impaired nerve myelination, increased demyelination, and altered cortical thickness and gray matter volume.

Regarding functional abnormalities, disrupted communications between brain regions and altered strength of neural connections are primarily associated with psychosis.

T1-weighted imaging (T1) and diffusion tensor imaging (DTI) are non-invasive neuroimaging methods to assess structural changes in the brain network. Resting-state functional connectivity (rs-FC) is another non-invasive technique used for functional assessment of the brain network.  

In this systematic review and meta-analysis, scientists have compared the effectiveness of different neuroimaging methods in classifying individuals with schizophrenia spectrum disorders from healthy individuals. Moreover, they have evaluated whether statistical, methodological, and demographic information can influence psychosis classification.

Study design

Scientists searched various scientific databases to identify studies that applied machine learning classification models to classify individuals with schizophrenia spectrum disorders using neuroimaging data of the whole-brain network. This was the primary inclusion criterion for the meta-analysis. Another inclusion criterion was the presence of internal cross-validation or external dataset validation.   

The effectiveness of three neuroimaging methods including T1, DTI, and rs-FC in classifying schizophrenia spectrum disorders was evaluated in the meta-analysis. Studies with internal prediction (within dataset cross-validation) and external prediction (validation in a new dataset) were analyzed separately.

Important observations

A total of 95 and 93 studies were selected for qualitative and quantitative analyses, respectively. Among these studies, 30 used T1, 9 used DTI, 40 used rs-FC, and 14 used a combination of these methods to classify schizophrenia spectrum disorders.

The study analysis revealed that all tested neuroimaging methods have moderate abilities to predict schizophrenia spectrum disorders. Notably, no significant difference in classification performance was observed between the tested methods. However, considering external datasets, rs-FC was found to outperform T1 in classifying schizophrenia spectrum disorders from health participants.

A high level of heterogeneity was observed across the study findings. Specifically, reported effect sizes within each imaging group appeared asymmetric. This indicates the presence of systematic bias in previous reports of the classification of schizophrenia spectrum disorders.

A separate analysis conducted after removing studies with large heterogeneity indicated similar findings, i.e., no significant differences between methods, except for rs-FC which outperformed DTI when internal datasets were used for classification, and T1 when external datasets were used for classification.

No significant difference in classification performance was observed between single-method (unimodal) and combined-method (multimodal) approaches. Both rs-FC and multimodal approaches showed largely overlapping performance in classifying schizophrenia spectrum disorders.

No significant impact of the statistical, methodological, and demographic information on schizophrenia spectrum disorder classification was observed in the analysis. The analysis of head motion, which is a major confounding factor in neuroimaging analyses, revealed no significant impact on classification performance.

Study significance

This systematic review and meta-analysis reveal that commonly used structural and functional neuroimaging methods are able to classify schizophrenia spectrum disorders.

The modalities tested exhibited similar performances in terms of classifying psychosis, although in some specific cases, the rs-FC method, which measures functional aspects of the brain network, showed slight advantages in terms of better classification performance compared to structural methods including DTI and T1.

Notably, the study highlights that the multimodal approaches do not have any advantage over unimodal approaches in classifying schizophrenia spectrum disorders and that rs-FC is sufficient to provide the required information for classification.

As mentioned by the scientists, this systematic review included studies with relatively smaller sample sizes than the recommended size. Thus, they could not certainly validate whether multimodal methods provide significant advantages in analyses involving large sample sizes.

In this meta-analysis, only whole-brain network data and rs-FC-based functional connectivity data were included. Thus, the scientists recommend that future systematic reviews should consider evaluating the involvement of specific brain regions as well as the ability of different functional connectivity methods, such as task-based FC and dynamic approaches, in classifying psychosis.​​​​​

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, August 14). Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20230814/Study-examines-unimodal-vs-multimodal-neuroimaging-methods-for-classifying-psychosis.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20230814/Study-examines-unimodal-vs-multimodal-neuroimaging-methods-for-classifying-psychosis.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis". News-Medical. https://www.news-medical.net/news/20230814/Study-examines-unimodal-vs-multimodal-neuroimaging-methods-for-classifying-psychosis.aspx. (accessed November 24, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20230814/Study-examines-unimodal-vs-multimodal-neuroimaging-methods-for-classifying-psychosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New neuroimaging marker may identify persons at risk of dementia in future clinical trials